Prostaglandin F2 receptor negative regulator (PTGFRN), a tumorigenesis-related gene, was associated with interleukin (IL)-12-mediated tumor recognition and killing efficacy for drugs [62, 63]. The gene discussed is PTGFRN; the disease is neoplasm.